Prevention of cytomegalovirus disease in transplant recipients [16]

Lancet

Volumn 347, Issue 8996, 1996, Pages 268-269

  Snydman, D R ^a   Falagas, M E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR;

CYTOMEGALOVIRUS INFECTION; HUMAN; INFECTION PREVENTION; INTRAVENOUS DRUG ADMINISTRATION; LETTER; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT;

EID: 0030022674     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90449-3     Document Type: Letter

References (5)

1. Dj Winston Prevention of cytomegalovirus disease in transplant recipients Lancet 346 1995 1380
2. Dj Winston D. Wirin A. Shaket Rw Busuttil Randomised comparison of ganciclovir and high dose acyclovir for long term cytomegalovirus prophylaxis in liver transplant recipients Lancet 346 1995 69 74
3. Tc Merigan Dg Renlund S. Keay A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation N Engl J Med 326 1992 1182 1186
4. Dr Snydman Bg Werner B. Heinze-Lacey Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients N Engl J Med 317 1987 1049 1054
5. Dr Snydman Bg Werner Nn Dougherty Cytomegalovirus immune globulin prophylaxis in liver transplantation: a randomised, double-blind, placebo controlled trial Ann Intern Med 119 1993 984 991